Biological Safety Testing for Monoclonal Antibodies Market Research Report – Segmentation by Products and Services (Consumables, Instruments, Services); Test Type (Bioburden Tests, Endotoxin Tests, Sterility Tests, Others); End-User (Academic and Research Institutes, Contract Development and Manufacturing Companies, Biotechnology, and Pharmaceutical Companies); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15116
Format:
Region: Global
Chapter 1. BIOLOGICAL SAFETY TESTING FOR MONOCLONAL ANTIBODIES MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. BIOLOGICAL SAFETY TESTING FOR MONOCLONAL ANTIBODIES MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. BIOLOGICAL SAFETY TESTING FOR MONOCLONAL ANTIBODIES MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. BIOLOGICAL SAFETY TESTING FOR MONOCLONAL ANTIBODIES MARKET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. BIOLOGICAL SAFETY TESTING FOR MONOCLONAL ANTIBODIES MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. BIOLOGICAL SAFETY TESTING FOR MONOCLONAL ANTIBODIES MARKET – by Products and Services
6.1. Consumables
6.2. Instruments
6.3. Services
Chapter 7. BIOLOGICAL SAFETY TESTING FOR MONOCLONAL ANTIBODIES MARKET – By Test Type
7.1. Bioburden Tests
7.2. Endotoxin Tests
7.3. Sterility Tests
7.4. Others
Chapter 8. BIOLOGICAL SAFETY TESTING FOR MONOCLONAL ANTIBODIES MARKET – By End-user
8.1. Academic and Research Institutes
8.2. Contract Development and Manufacturing Companies
8.3. Biotechnology and Pharmaceutical Companies
Chapter 9. BIOLOGICAL SAFETY TESTING FOR MONOCLONAL ANTIBODIES MARKET – By Region
9.1. North America
9.2. Europe
9.3.The Asia Pacific
9.4.Latin America
9.5. Middle-East and Africa
Chapter 10. BIOLOGICAL SAFETY TESTING FOR MONOCLONAL ANTIBODIES MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)
10.1. Charles River Laboratories International, Inc. (United States)
10.2. Lonza Group AG (Switzerland)
10.3. Thermo Fisher Scientific Inc. (United States)
10.4. The Merck Group (Germany)
10.5. SGS S.A. (Switzerland)
10.6. WuXi AppTec (China)
10.7. Eurofins Scientific SE (Luxembourg)
10.8. Bio-Rad Laboratories, Inc. (United States)
10.9. Nelson Laboratories, LLC (United States)
10.10. Mabtech AB (Sweden)
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The global Biological Safety Testing for Monoclonal Antibodies Market is estimated to be worth USD 720.00 Million in 2022 and is projected to reach a value of USD 1955.11 Million by 2030, growing at a CAGR of 13.3% during the forecast period 2023-2030.
The Global Biological Safety Testing for Monoclonal Antibodies Market Drivers are the Utilization of Monoclonal Antibodies in Cancer Therapy and the Authorization of Sotrovimab for the Treatment of Mild-to-Moderate COVID-19 Infections
Based on the Products and Services, the Global Biological Safety Testing for Monoclonal Antibodies Market is segmented into Consumables, Instruments, and Services.
The United States is the most dominating country in the region of North America for the Global Biological Safety Testing for Monoclonal Antibodies Market.
Charles River Laboratories International, Inc., Lonza Group AG, and Thermo Fisher Scientific Inc. are the leading players in the Global Biological Safety Testing for Monoclonal Antibodies Market.
